Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells

Autor(es):Mostrar menos -

Los, Bruna ; Ferreira, Glaucio Monteiro ; Borges, Jessica Bassani ; Kronenberger, Thales ; Oliveira, Victor Fernandes de ; Dagli-Hernandez, Carolina ; Bortolin, Raul Hernandes ; Goncalves, Rodrigo Marques ; Faludi, Andre Arpad ; Mori, Augusto Akira ; Barbosa, Thais Kristini Almendros ; Freitas, Renata Caroline Costa de ; Jannes, Cinthia Elim ; Pereira, Alexandre da Costa ; Bastos, Gisele Medeiros ; Poso, Antti ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki

• Tipo de documento: Artigo Científico
• Fonte: Gene; v. 851, p. 14-pg., 2023-01-30.

Resumo

PCSK9 gain-of-function (GOF) variants increase degradation of low-density lipoprotein receptor (LDLR) and are potentially associated with Familial Hypercholesterolemia (FH). This study aimed to explore the effects of PCSK9 missense variants on protein structure and interactions with LDLR using molecular modeling analyses and in vitro functional studies. Variants in FH-related genes were identified in a Brazilian FH cohort using an exon-target gene sequencing strategy. Eight PCSK9 missense variants in pro-[p.(E32K) and p.(E57K)], catalytic [p. (R237W), p.(P279T) and p.(A443T)], and C-terminal histidine-cysteine rich (CHR) [p.(R469W), p.(Q619P) and p.(R680Q)] domains were identified. Molecular dynamics analyses revealed that GOF variants p.(E32K) and p. (R469W) increased extreme motions in PCSK9 amino acid backbone fluctuations and affected Hbond and water bridge interactions between the pro-domain and CM1 region of the CHR domain. HEK293FT cells transfected with plasmids carrying p.(E32K) and p.(R469W) variants reduced LDLR expression (8.7 % and 14.8 %, respectively) compared to wild type (p < 0.05) but these GOF variants did not affect PCSK9 expression and secretion. The missense variants p.(P279T) and p.(Q619P) also reduced protein stability and altered Hbond interactions. In conclusion, PCSK9 p.(E32K), p.(R469W), p.(P279T) and p.(Q619P) variants disrupt intra-molecular interactions that are essential for PCSK9 structural conformation and biological activity and may have a potential role in FH pathogenesis. (AU)

• Processo FAPESP: 16/12899-6 - Caracterização genômica, epigenômica e farmacogenômica de portadores de hipercolesterolemia familial na população brasileira
• Beneficiário: Mario Hiroyuki Hirata
• Modalidade de apoio: Auxílio à Pesquisa - Temático